Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Chronic myelocytic leukemia and the myeloproliferative diseases during the child-bearing years

Journal Article · · J. Reprod. Med.; (United States)
OSTI ID:5354893
Chronic myelocytic leukemia and the myeloproliferative diseases may present as asymptomatic elevations of peripheral blood counts or with relatively nonspecific symptoms. Full diagnostic evaluation is necessary to eliminate the many other causes of blood count elevation. Coincidence of a myeloproliferative disease and pregnancy is unusual. The pregnancy has no adverse effect on the course of the mother's hematologic disease. However, the myeloproliferative diseases, especially if uncontrolled, result in increased fetal prematurity and mortality. Treatment of the pregnant patient should be conservative, and cytotoxic therapy should be avoided until at least after the first trimester whenever possible. Busulfan has been the drug most widely used during pregnancy, and it appears not to cause fetal malformations when used alone.
Research Organization:
Univ. of Chicago
OSTI ID:
5354893
Journal Information:
J. Reprod. Med.; (United States), Journal Name: J. Reprod. Med.; (United States) Vol. 17:4; ISSN JRPMA
Country of Publication:
United States
Language:
English

Similar Records

RAS gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders, and myelodysplastic syndromes
Journal Article · Mon Nov 30 23:00:00 EST 1987 · Proc. Natl. Acad. Sci. U.S.A.; (United States) · OSTI ID:6271190

Acute leukemia during reproductive life: its course, complications, and sequelae for fertility
Journal Article · Fri Oct 01 00:00:00 EDT 1976 · J. Reprod. Med.; (United States) · OSTI ID:7086842

Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia
Journal Article · Fri Sep 01 00:00:00 EDT 1989 · Proceedings of the National Academy of Sciences of the United States of America; (USA) · OSTI ID:6968735